Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO05160)
Xenobiotics Name
Toremifene
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Approved/Marketed Drug
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3005573"></iframe>
3D MOL 2D MOL
PubChem CID
3005573
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
D-Lactate dehydrogenase (ldhA) DME Info Pseudomonas aeruginosa [1]
Arylamine N-acetyltransferase (NAT) DME Info Pseudomonas aeruginosa [1]
NADPH-dependent oxidoreductase (nfrA) DME Info Staphylococcus aureus [1]
Hydroxybenzoate 3-monooxygenase (pobA) DME Info Pseudomonas aeruginosa [1]
References
1 Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo. Antimicrob Agents Chemother. 2014 Dec;58(12):7606-10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.